Furthermore, tumor-normal comparison of promoter methylation (Δβ values) demonstrated consistent CCT4 hypomethylation in various cancers, including BLCA, COAD, LUAD, LUSC, and PRAD (Figure 6E). Here, CCT4 is linked to neoplasm.